Local Manufacturer Listing GN-08: Five-Year Validity and Site Inspection

1. Key takeaways

GN-08, Guidance Notes on Listing of Local Manufacturers of Medical Devices, was updated on 1 September 2026 and contains three provisions that matter most to a manufacturer. Clause 4.10 requires the applicant to cooperate with a site inspection requested by the Medical Device Division (MDD) during the application period or after approval, including providing records and written procedures and allowing inspection of the business premises and related storage or transport facilities. Clause 5.6.1 sets the listing validity at 5 years, unless the Local Manufacturer Listing Approval Committee decides otherwise. Clause 5.8.1 requires a renewal application to be submitted between 12 weeks and 1 year before expiry.

Read together, the three provisions describe a listing that is granted on evidence, kept on inspection readiness and lost by calendar management. The inspection clause is the substantive change in posture: it moves the test from what the file says to what the premises show. The validity and renewal clauses convert the listing into a fixed-term status with a narrow re-entry window.

A local manufacturer in Hong Kong, China is therefore not buying a certificate. It is accepting a five-year operating commitment with a defined inspection surface and a hard deadline for renewal, and the cost of missing that deadline is a fresh application rather than an administrative penalty.

2. Legal basis

GN-08 was reissued in updated form on 1 September 2026. Clause 4.10 deals with site inspection, clause 5.6.1 with the five-year validity, clause 5.7 with additional conditions and clause 5.8.1 with the renewal window. The operating requirements sit in COP-03, Code of Practice for Listed Local Manufacturers of Medical Devices, updated on the same date. GN-01, updated and issued on 1 September 2026, provides at clause 5.10 for approval subject to additional conditions, and MDD announced the package through its developments page on 1 September 2026.

The inspection provision is drafted broadly on purpose. It covers the business premises and, separately, related storage or transport facilities, which means the evidence surface extends beyond the manufacturing room to the warehouse and the distribution chain. Records and written procedures are named as inspection objects in their own right, so an inspection can fail on documentation even where the physical operation is sound.

3. Expert insights

The inspection clause turns paper compliance into site compliance. Clause 4.10 expressly extends the inspection scope to the business premises and to related storage or transport facilities. Warehouse temperature and humidity records, transport condition validation and cold chain logistics documentation therefore fall within what can be examined. Manufacturers that maintain a clean quality manual but a loosely documented warehouse are exposed under this clause in a way they were not under a purely documentary review.

The validity clause is new in this revision, but the renewal mechanism is not. The official revision record marks the validity provision in clause 5.6.1 as added in September 2026, while the renewal mechanism itself appeared in the revision of December 2025. Describing the whole renewal mechanism as newly created in September 2026 would be inaccurate, and this is a detail that is easy to misread. The practical consequence of the distinction is that companies which built renewal procedures last year already have the process; what changed this year is the certainty of the five-year term.

A discrepancy between the code and the guidance requires clarification. Clause 2.12.1 of COP-03, dealing with an already listed local manufacturer, uses a 3-year formulation and points to the distributor list, which is inconsistent with the 5-year formulation for manufacturers in clause 5.6.1 of GN-08. Manufacturers should follow GN-08 and seek written clarification from MDD on the inconsistency, a practical estimate of the correct reading rather than a settled position. Keeping the written reply on file turns an ambiguity into a defensible record.

Expiry means starting again. Clause 5.8.1 provides that a renewal application outside the window will not be accepted. Once a listing expires, a fresh application is required, which in effect repeats the 12-week approval process and resets the inspection exposure. The difference between renewing on time and re-applying is therefore not a fee difference; it is a gap in status during which the manufacturer cannot rely on its listing.

The inspection is not confined to the application period. Because clause 4.10 applies during the application period or after approval, inspection readiness is a permanent operating condition. A manufacturer that assembles records only when an application is pending will be visibly unprepared when an inspection is requested at short notice.

4. Practical recommendations

• Make inspection readiness routine. Keep records, written procedures, and storage and transport conditions in a state that can be produced on request, rather than assembling them when a visit is announced.
• Set two renewal reminders. Schedule one at 1 year before expiry and one at 16 weeks before expiry, so that submission falls inside the 12-week to 1-year window with time for queries.
• Clarify the code discrepancy in writing. Put the question on clause 2.12.1 of COP-03 and clause 5.6.1 of GN-08 to MDD, and retain the reply as the basis for internal procedures.
• Register additional conditions. Record each condition attached under clause 5.7 with its performance deadline and evidence requirement.
• Align warehouse and transport contracts with the inspection scope. Where storage or transport is outsourced, secure access and record availability contractually, since the inspection right extends to those facilities.

5. Verification checklist

• □ GN-08 confirmed as the version updated on 1 September 2026.
• □ Records and written procedures required for site inspection ready for production on request.
• □ Storage and transport facilities self-checked against the inspection scope.
• □ Listing validity of 5 years and the expiry date registered in the compliance calendar.
• □ Renewal reminders set at 1 year and 16 weeks before expiry.
• □ Discrepancy between COP-03 clause 2.12.1 and GN-08 clause 5.6.1 raised with MDD in writing.
• □ Additional conditions under clause 5.7 registered with deadlines and owners.

Regulatory information verified as at 29 October 2026 against the official sources listed under legal basis; where those sources are updated, the latest published version prevails.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Hong Kong, China. Our team coordinates local responsible persons, import and wholesale dealer licensing, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com